NCRA vs CLPS vs CODA vs RELI vs GOCO vs JPM

For growth investors, Coda Octopus Group, Inc.

(CODA) is the stronger pick with 30. 7% revenue growth year-over-year, versus -54. 7% for GoHealth, Inc. (GOCO). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 8x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Coda Octopus Group, Inc. (CODA) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 15. 8x versus Coda Octopus Group, Inc. at 31. 9x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 1. 08x versus Coda Octopus Group, Inc. 's 5. 20x — a reasonable growth-adjusted valuation.

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +102. 5%, compared to -100. 0% for Reliance Global Group, Inc. (RELI). Over 10 years, the gap is even starker: CODA returned +633. 6% versus RELI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CLPS Incorporation (CLPS) is the lower-risk stock at 0.

18β versus GoHealth, Inc. 's 1. 99β — meaning GOCO is approximately 985% more volatile than CLPS relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 4% for Reliance Global Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Coda Octopus Group, Inc.

(CODA) is pulling ahead at 30. 7% versus -54. 7% for GoHealth, Inc. (GOCO). On earnings-per-share growth, the picture is similar: JPMorgan Chase & Co. grew EPS 21. 7% year-over-year, compared to -29. 6% for GoHealth, Inc.. Over a 3-year CAGR, RELI leads at 13. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 21. 6% net margin versus -71. 1% for GoHealth, Inc. — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 27. 7% versus -54. 8% for RELI. At the gross margin level — before operating expenses — GOCO leads at 73. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 1. 08x versus Coda Octopus Group, Inc. 's 5. 20x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 0x forward P/E versus 22. 3x for Coda Octopus Group, Inc. — 8. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CODA: 18. 6% to $14. 00.

In this comparison, CLPS (15.

2% yield), JPM (1. 6% yield) pay a dividend. NCRA, CODA, RELI, GOCO do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

18), 15. 2% yield). GoHealth, Inc. (GOCO) carries a higher beta of 1. 99 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLPS: -79. 1%, GOCO: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NCRA (Consumer Defensive) and CLPS (Technology) and CODA (Industrials) and RELI (Financial Services) and GOCO (Financial Services) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NCRA is a small-cap quality compounder stock; CLPS is a small-cap high-growth stock; CODA is a small-cap high-growth stock; RELI is a small-cap quality compounder stock; GOCO is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. CLPS, JPM pay a dividend while NCRA, CODA, RELI, GOCO do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.